Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Obesity and lipodystrophy--where do the circles intersect?

Chehab FF.

Endocrinology. 2008 Mar;149(3):925-34. doi: 10.1210/en.2007-1355. Epub 2008 Jan 17. Review.

2.

Adipose tissue as an endocrine organ.

Galic S, Oakhill JS, Steinberg GR.

Mol Cell Endocrinol. 2010 Mar 25;316(2):129-39. doi: 10.1016/j.mce.2009.08.018. Epub 2009 Aug 31. Review.

PMID:
19723556
3.

Resistance to high-fat diet-induced obesity but exacerbated insulin resistance in mice overexpressing preadipocyte factor-1 (Pref-1): a new model of partial lipodystrophy.

Villena JA, Choi CS, Wang Y, Kim S, Hwang YJ, Kim YB, Cline G, Shulman GI, Sul HS.

Diabetes. 2008 Dec;57(12):3258-66. doi: 10.2337/db07-1739. Epub 2008 Oct 3.

4.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

5.

Mouse models of inherited lipodystrophy.

Savage DB.

Dis Model Mech. 2009 Nov-Dec;2(11-12):554-62. doi: 10.1242/dmm.002907. Review.

6.

Adipose tissue as a buffer for daily lipid flux.

Frayn KN.

Diabetologia. 2002 Sep;45(9):1201-10. Epub 2002 Jul 24. Review.

PMID:
12242452
7.

Adipose tissue as an endocrine organ: impact on insulin resistance.

Jazet IM, Pijl H, Meinders AE.

Neth J Med. 2003 Jun;61(6):194-212. Review.

8.

Mouse models of lipodystrophy and their significance in understanding fat regulation.

Rochford JJ.

Curr Top Dev Biol. 2014;109:53-96. doi: 10.1016/B978-0-12-397920-9.00005-6. Review.

PMID:
24947236
9.

Molecular mechanisms of human lipodystrophies: from adipocyte lipid droplet to oxidative stress and lipotoxicity.

Vigouroux C, Caron-Debarle M, Le Dour C, Magré J, Capeau J.

Int J Biochem Cell Biol. 2011 Jun;43(6):862-76. doi: 10.1016/j.biocel.2011.03.002. Epub 2011 Mar 8. Review.

PMID:
21392585
10.

Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ.

Trayhurn P, Beattie JH.

Proc Nutr Soc. 2001 Aug;60(3):329-39. Review.

PMID:
11681807
11.

Metabolic consequences of lipodystrophy in mouse models.

Reue K, Phan J.

Curr Opin Clin Nutr Metab Care. 2006 Jul;9(4):436-41. Review.

PMID:
16778573
12.

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T.

Nat Med. 2001 Aug;7(8):941-6.

PMID:
11479627
13.

Mouse models of lipodystrophy.

Reue K, Péterfy M.

Curr Atheroscler Rep. 2000 Sep;2(5):390-6. Review.

PMID:
11122770
14.

[Lipodystrophic syndromes: congenital or acquired diseases of adipose tissue].

Capeau J, Vigouroux C, Magré J, Lascols O, Caron M, Bastard JP.

C R Biol. 2006 Aug;329(8):639-52; discussion 653-5. Epub 2006 Apr 27. French.

PMID:
16860281
15.

Lipodystrophy: Syndrome of severe insulin resistance.

Bindlish S, Presswala LS, Schwartz F.

Postgrad Med. 2015 Jun;127(5):511-6. doi: 10.1080/00325481.2015.1015927. Epub 2015 Feb 17. Review.

PMID:
25690482
16.

Resistin and obesity-associated insulin resistance.

Steppan CM, Lazar MA.

Trends Endocrinol Metab. 2002 Jan-Feb;13(1):18-23. Review.

PMID:
11750858
18.

Diabetes, lipids, and adipocyte secretagogues.

Faraj M, Lu HL, Cianflone K.

Biochem Cell Biol. 2004 Feb;82(1):170-90. Review.

PMID:
15052336
19.
20.

Resistin/ADSF/FIZZ3 in obesity and diabetes.

Sul HS.

Trends Endocrinol Metab. 2004 Aug;15(6):247-9.

PMID:
15358276

Supplemental Content

Support Center